---
title: Link imagining movements to frailty
nct_id: NCT07488364
status: RECRUITING
sponsor: Acibadem University
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07488364"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07488364"
last_fetched: "2026-07-15T14:01:45.254Z"
source: "Parkinson's Pathways (curated)"
---
# Link imagining movements to frailty

**Goal (in five words):** Link imagining movements to frailty

**Official Title:** Investigation of the Relationship Between Motor Imagery, Body Awareness, Kinesiophobia, Physical Activity, Symptom Severity, and Physical Frailty in Patients With Parkinson's Disease

**Trial ID:** [NCT07488364](https://clinicaltrials.gov/study/NCT07488364)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Acibadem University
- **Target Enrollment:** 100 participants
- **Start Date:** 2026-03-30
- **Completion Date:** 2026-12-30
- **Conditions:** Parkinson Disease
- **Interventions:** Observational Questionnaire and Functional Assessment
- **Intervention Types:** OTHER

## Summary For Families

It looks at whether a person’s ability to imagine movements, awareness of internal body signals, fear of moving, activity level, and symptom severity are linked to physical frailty in Parkinson's. Participants will answer questionnaires and do simple physical tests during a single visit so researchers can compare these measures. The study seeks people aged 40 to 85 with a clinical Parkinson's diagnosis in early to mid stages (Hoehn and Yahr stages 1 to 3) who can follow instructions and have a Mini-Mental State Examination score of 24 or higher. People with major depression or psychosis, advanced dementia, serious heart or lung disease, uncontrolled chronic illnesses, other neurologic or orthopedic problems that affect testing, or severe vision or hearing loss are not eligible.

## What This Actually Involves

**Placebo** _(From the protocol)_: This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.

**Visits** _(Ask the coordinator)_: Ask the coordinator how many in-person visits the study involves, how long each one takes, and over what total period.

**Procedures** _(From the protocol)_:
- Questionnaires & surveys (Non-invasive)
  > "Observational Questionnaire and Functional Assessment"

**Washout** _(Ask the coordinator)_: Ask the coordinator whether you would need to stop or pause any of your current medications before or during the study (a washout period), and for how long.

**Travel & reimbursement** _(Ask the coordinator)_: Ask the coordinator whether travel, parking, or your time is reimbursed or compensated, and what is covered.

_Fields marked “From the protocol” come from the trial's registry record or quoted protocol text. Fields marked “Ask the coordinator” are not reliably available and should be confirmed directly._

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinically diagnosed Parkinson's disease
* Hoehn and Yahr stage 1-3
* Age 40 to 85 years
* Mini-Mental State Examination (MMSE) score ≥24
* Attending the Movement Disorders Outpatient Clinic, Department of Neurology
* Able to understand the study procedures and provide written informed consent

Exclusion Criteria:

* Major depressive disorder or psychotic disorder
* Advanced dementia
* Severe cardiovascular or respiratory disease
* Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
* Additional neurological or orthopedic conditions that may affect assessment performance
* Severe visual or hearing impairment that could interfere with study assessments
* Inability to cooperate with the physiotherapist during study assessments
```

## Locations (1)

- Acibadem University, Istanbul, Turkey, Turkey (Türkiye) _(41.0138, 28.9497)_
  - Nuray ALACA, (CONTACT), 05324251290, nuray.alaca@acibadem.edu.tr

## Central Contacts

- Nuray ALACA, (CONTACT), 05324251290, nuray.alaca@acibadem.edu.tr

---

*Canonical: https://parkinsonspathways.com/trial/NCT07488364*  
*HTML version: https://parkinsonspathways.com/trial/NCT07488364*  
*Source data: https://clinicaltrials.gov/study/NCT07488364*